Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,754.00
Bid: 1,762.00
Ask: 1,768.00
Change: -42.00 (-2.34%)
Spread: 6.00 (0.341%)
Open: 1,822.00
High: 1,822.00
Low: 1,750.00
Prev. Close: 1,796.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

5 Mar 2018 18:38

RNS Number : 7608G
Genus PLC
05 March 2018
 

5 March 2018

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces the following Director/PDMR Shareholding transactions:

· Jonathan Lightner, Chief Scientific Officer & Head of Genus R&D, sold 2,969 ordinary shares in the Company on 1 March 2018 on the London Stock Exchange at a price of 2,200 pence per share;

 

· Further to the vesting of contingent rights over ordinary shares in Genus on 28 February 2018 under an individual restricted stock award agreement (the 'RSA'), Dr. Nate Zwald, a member of the Genus Executive Leadership Team ('GELT'), sold ordinary shares in Genus on 2 March 2018, on the London Stock Exchange to offset income tax and social security liabilities due on the exercise, and retained the balance of ordinary shares; and

 

· Further to the vesting of conditional nil-cost options on 20 November 2017 under the Genus Deferred Share Bonus Plan (the 'DSBP') and the Genus 2014 Performance Share Plan (the 'PSP'), Bill Christianson, a member of GELT, sold ordinary shares in Genus on 2 March 2018 and 5 March 2018 respectively, on the London Stock Exchange to offset income tax and social security liabilities due on the exercises, and retained the balance of ordinary shares.

 

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of nil-cost options and contingent rights exercised and ordinary shares sold.

 

 

For further information please contact:

 

Genus:

Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

 

Table A - GELT Private Share Sale

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Lightner

2.

Reason for the notification

a.

Position/status

Chief Scientific Officer & Head of Genus R&D

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of 2,969 ordinary shares.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,200p

2,969

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

Average price(s)

 

Total volume(s)

2,200p

2,969

e.

Date of the transaction

2018-03-01

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Restricted Stock Award Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Dr. Nate Zwald

2.

Reason for the notification

a.

Position/status

Chief Operating Officer, Genus ABS Dairy

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 3,613 contingent rights under the RSA.

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

3,613

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

0p

3,613

e.

Date of the transaction

2018-03-02

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

b.

Nature of the transaction

Sale of 1,352 shares arising from the exercise of contingent rights under the RSA to offset income tax and social security liabilities due on the exercise.

c.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,208p

1,352

d.

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

2,208p

1,352

e.

Date of the transaction

2018-03-02

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

Table C - GELT Deferred Share Bonus Plan Exercise 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Bill Christianson

2.

Reason for the notification

a.

Position/status

Chief Operating Officer, Genus PIC

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 1,515 nil-cost options under the DSBP.

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

1,515

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

0p

1,515

e.

Date of the transaction

2018-03-02

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

e.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

f.

b.

Nature of the transaction

Sale of 608 shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

g.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,208p

608

h.

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

2,208p

608

e.

Date of the transaction

2018-03-02

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

Table D - GELT 2014 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Bill Christianson

2.

Reason for the notification

a.

Position/status

Chief Operating Officer, Genus PIC

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 21,827 nil-cost options under the PSP.

 

 

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

21,827

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

Average price(s)

 

Total volume(s)

0p

21,827

e.

Date of the transaction

2018-03-05

f.

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

GB0002074580

b.

Nature of the transaction

Sale of 8,758 shares arising from the exercise of nil-cost options under the PSP to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,191.7014p

8,758

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

2,191.7014p

8,758

e.

Date of the transaction

2018-03-05

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUVOWRWSAORAR
Date   Source Headline
3rd Nov 20227:00 amRNSRuthin Site Visit
14th Oct 202211:39 amRNSTR-1: Notification of Major Holdings
14th Oct 20227:00 amRNSAnnual Report and Annual General Meeting
15th Sep 202210:55 amRNSNotification of Major Holdings
14th Sep 20224:41 pmRNSDirector/PDMR Shareholding
13th Sep 20226:08 pmRNSDirector/PDMR Shareholding
8th Sep 20221:57 pmRNSNotification of Major Holdings
8th Sep 20227:00 amRNSPreliminary Results
2nd Sep 20229:05 amRNSTotal Voting Rights
2nd Aug 20227:00 amRNSAppointment of Joint Corporate Broker
1st Aug 202210:10 amRNSBlock listing Interim Review
21st Jul 202210:21 amBUSForm 8.3 - Genus Plc - CORRECTION
21st Jul 202210:05 amRNSHolding(s) in Company
20th Jul 20223:03 pmRNSNotification of Major Holdings
19th Jul 202211:57 amBUSForm 8.3 - Genus Plc
5th Jul 20222:10 pmRNSNotification of Major Holdings
1st Jul 20229:35 amRNSTotal Voting Rights
24th Jun 20223:42 pmRNSNotification of Major Holdings
6th Jun 20229:11 amRNSNotification of Major Holdings
1st Jun 202212:45 pmRNSNotification of Major Holdings
30th May 202212:18 pmRNSNotification of Major Holdings
17th May 20229:26 amRNSNotification of Major Holdings
21st Apr 20227:00 amRNSNotification of Major Holdings
19th Apr 20221:50 pmRNSNotification of Major Holdings
31st Mar 20221:34 pmRNSDirector Declaration
28th Mar 20225:36 pmRNSNotification of Major Holdings
8th Mar 20223:47 pmRNSNotification of Major Holdings
8th Mar 20221:13 pmRNSNotification of Major Holdings
24th Feb 20227:00 amRNSCollaboration between PIC and Olymel LP in Canada
24th Feb 20227:00 amRNSInterim Results
1st Feb 20224:57 pmRNSBlock listing Interim Review
4th Jan 20229:47 amRNSTotal Voting Rights
26th Nov 202110:18 amRNSDisclosure of Rights Attached to Equity Shares
24th Nov 20215:51 pmRNSDirector/PDMR Shareholding
24th Nov 20212:47 pmRNSResult of AGM
24th Nov 20212:30 pmRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSAGM Trading Update
10th Nov 20212:28 pmRNSNotification of Major Holdings
15th Oct 20217:00 amRNSAnnual Report and Annual General Meeting
13th Oct 20215:56 pmRNSDirector/PDMR Shareholding
1st Oct 20213:58 pmRNSTotal Voting Rights
30th Sep 20219:59 amRNSDirector Declaration
29th Sep 20212:59 pmRNSNotification of Major Holdings
15th Sep 20214:45 pmRNSDirector/PDMR Shareholding
14th Sep 20214:32 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSPreliminary Results
1st Sep 20212:05 pmRNSTotal Voting Rights
2nd Aug 20214:00 pmRNSBlock listing Interim Review
2nd Aug 202110:09 amRNSTotal Voting Rights
1st Jul 20214:39 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.